PhytoNanotechnology: enhancing delivery of plant based anti-cancer drugs
T Khan, P Gurav - Frontiers in pharmacology, 2018 - frontiersin.org
Natural resources continue to be an invaluable source of new, novel chemical entities of
therapeutic utility due to the vast structural diversity observed in them. The quest for new and …
therapeutic utility due to the vast structural diversity observed in them. The quest for new and …
Review of recently used techniques and materials to improve the efficiency of orally administered proteins/peptides
YHEY Ibrahim, G Regdon, EI Hamedelniel… - DARU Journal of …, 2020 - Springer
Objectives The main objective of present review is to explore and evaluate the effectiveness
of recently developed methods to improve the bioavailability of orally administered …
of recently developed methods to improve the bioavailability of orally administered …
Celecoxib-loaded solid lipid nanoparticles for colon delivery: formulation optimization and in vitro assessment of anti-cancer activity
This work aimed to optimize a celecoxib (CXB)-loaded solid lipid nanoparticles (SLN) colon
delivery system for the enhancement of anticancer activity. An ultrasonic melt-emulsification …
delivery system for the enhancement of anticancer activity. An ultrasonic melt-emulsification …
Lipid nanocarriers based on natural oils with high activity against oxygen free radicals and tumor cell proliferation
The development of nano-dosage forms of phytochemicals represents a significant progress
of the scientific approach in the biomedical research. The aim of this study was to assess the …
of the scientific approach in the biomedical research. The aim of this study was to assess the …
Tween 80-Based Self-Assembled Mixed Micelles Boost Valsartan Transdermal Delivery
AEB Yassin, S Massadeh, AA Alshwaimi, RH Kittaneh… - Pharmaceuticals, 2023 - mdpi.com
Valsartan (Val) is an important antihypertensive medication with poor absorption and low
oral bioavailability. These constraints are due to its poor solubility and dissolution rate. The …
oral bioavailability. These constraints are due to its poor solubility and dissolution rate. The …
[PDF][PDF] Carbohydrate based nanoparticles for drug delivery across biological barriers
Review Page 1 Copyright © 2014 American Scientific Publishers All rights reserved Printed in
the United States of America Review Journal of Biomedical Nanotechnology Vol. 10, 2107–2148 …
the United States of America Review Journal of Biomedical Nanotechnology Vol. 10, 2107–2148 …
Tamoxifen citrate/coenzyme Q10 as smart nanocarriers bitherapy for breast cancer: cytotoxicity, genotoxicity, and antioxidant activity
ES El-Leithy, SA Hassan, RS Abdel-Rashid - Journal of Drug Delivery …, 2019 - Elsevier
Nanotechnology-based bitherapy has recently emerged as an effective strategy to overcome
biomedical barriers against successful anticancer therapy. The study aimed to evaluate lipid …
biomedical barriers against successful anticancer therapy. The study aimed to evaluate lipid …
Nanostructure-based platforms-current prospective in ophthalmic drug delivery
RK Sharma, AEB Yassin - Indian Journal of Ophthalmology, 2014 - journals.lww.com
The topically applied drugs as drops are washed off from the eye in very short period,
resulting in low ocular bioavailability of drugs. Number of approaches have been attempted …
resulting in low ocular bioavailability of drugs. Number of approaches have been attempted …
Di-block PLCL and tri-block PLCLG matrix polymeric nanoparticles enhanced the anticancer activity of loaded 5-fluorouracil
In the current study, 5-FU-loaded nanoparticles (NPs) were prepared using polylactic-co-
glycolic acid (PLGA), polycaprolactone (PCL), di-block poly lactide-co-caprolactone (PLCL) …
glycolic acid (PLGA), polycaprolactone (PCL), di-block poly lactide-co-caprolactone (PLCL) …
[图书][B] Cancer nanotheranostics
A wide range of FDA (Food and Drug Administration, US) approved synthetic and natural
polymers have already entered in medical and pharmaceutical markets (Mansour et al …
polymers have already entered in medical and pharmaceutical markets (Mansour et al …